Key regions: China, South Korea, Canada, India, France
The Analgesics (Pharmacies) market in Indonesia is experiencing steady growth due to changing customer preferences and increasing demand for pain relief medications.
Customer preferences: Customers in Indonesia are becoming more health-conscious and are actively seeking ways to manage their pain and discomfort. As a result, there is a growing preference for over-the-counter analgesics that can be easily purchased from pharmacies without a prescription. This shift in customer preferences towards self-medication is driving the demand for analgesics in the country.
Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in Indonesia is the increasing popularity of herbal and natural pain relief products. Customers are becoming more inclined towards products that are perceived to be safer and have fewer side effects. This has led to the introduction of a wide range of herbal analgesics in the market, which are gaining traction among consumers. Another trend in the market is the rising demand for combination analgesics. These are medications that contain two or more active ingredients to provide relief from multiple symptoms. Combination analgesics are preferred by customers as they offer a convenient and comprehensive solution for pain management.
Local special circumstances: Indonesia has a large population, which contributes to the growing demand for analgesics. The country's healthcare system is still developing, and access to medical professionals may be limited in certain areas. This has led to an increased reliance on pharmacies for healthcare advice and medication. Pharmacies play a crucial role in providing access to analgesics and other healthcare products to the population.
Underlying macroeconomic factors: The growing middle class and increasing disposable income in Indonesia are driving the demand for analgesics. As more people are able to afford healthcare products, the market for analgesics is expanding. Additionally, the aging population in Indonesia is also contributing to the growth of the market, as older individuals are more likely to experience chronic pain and require regular pain relief medication. In conclusion, the Analgesics (Pharmacies) market in Indonesia is witnessing growth due to changing customer preferences, including a shift towards self-medication and a preference for herbal and natural pain relief products. The market is also driven by local special circumstances, such as limited access to medical professionals and the role of pharmacies in providing healthcare advice and medication. The underlying macroeconomic factors, including the growing middle class and aging population, are further contributing to the expansion of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
